More specifically, it has been shown that the reduction of BTLA expression in tumor infiltrating lymphocytes (TILs), through targeting HVEM, might result in better tumor control in a humanized mouse model of PCa [52]. The gene discussed is BTLA; the disease is posterior cortical atrophy.